A subset of patients with severe obesity who kept taking retatrutide in a study extension continued to slim down, losing up to an average of 85 pounds, or 30% of their body weight, at two years, the company said in a statement detailing the Phase 3 trial results
Factors such as the convenience of administration, fear of needles, and cultural considerations can influence this decision
Supportive supplements can also help
Semaglutide is most effective when combined with healthy habits such as nutritious eating and regular movement
An increase warrants attention, especially if combined with symptoms like fatigue or abdominal discomfort
This is the same dual-agonist approach that made tirzepatide so effective, but retatrutide goes further